Susan Park Ochsner, Ph.D.
Susan received her B.A. degree (‘04) in Biology at Johns Hopkins University. After working for a number of years at the Institute of Human Virology, the FDA, and Aeras Global TB Vaccine Foundation, where she worked on HIV vaccine and diagnostic assay development, and clinical TB vaccine assessment, Susan entered the Ph.D. program of Biological Sciences at the University of Maryland, College Park. She joined the lab of Dr. Xiaoping Zhu where she developed a novel mucosal FcRn-mediated subunit vaccine for influenza. Susan completed her Ph.D. in 2018 and joined the lab of Dr. Dan Barouch shortly after, where she continues to work on developing subunit vaccines. Currently, Susan is developing novel HIV-1 Env trimers as vaccine candidates using the unique Signature-based Epitope Targeted (SET) mutation platform to induce tier 2 bNAbs responses in the guinea pig and NHP models.